Page not found

Search results

  1. CTTC commercialized 25 COVID-19-related discoveries, facilitated nine startups during record-setting year

    05/12/2021 The  Center for Technology Transfer and Commercialization  continued to play a pivotal role ... rehabilitation. IDBiologics  discovers and develops human monoclonal antibodies for the prevention, treatment and cure of ...

    sommers - 05/26/2021 - 10:39am

  2. Tech Connect, Vol. 7, Issue 3: CTTC launches Startup Vanderbilt's Pre-Flight Program

    ... Vanderbilt” initiative, the Vanderbilt Center for Technology Transfer and Commercialization and the Vanderbilt Innovation Center, ... Pipeline The vaccine pipeline lists antigens and human monoclonal antibodies available for license for vaccine development ...

    steelmk - 11/10/2016 - 7:45am

  3. Exoskeleton developed at Vanderbilt University collects R&D 100 Award

    ... the 100 most exceptional innovations in science and technology from the past year and are considered among the most globally ... a grant from the  National Institute of Child Health and Human Development . In 2012, Parker Hannifin, a global leader in motion and ...

    sommers - 02/21/2019 - 9:51am

  4. Tech Connect, Vol. 7, Issue 5: New study shows Play Nicely™ program is an effective positive parenting strategy

    ... Technology Spotlight:  microRNAs Inhibition of Selected ... Pipeline The vaccine pipeline lists antigens and human monoclonal antibodies available for license for vaccine development ...

    steelmk - 11/15/2016 - 2:29pm

  5. Vanderbilt-developed obesity treatments will be advanced through collaboration with Soleno Therapeutics

    ... partnership, which is facilitated by the  Center for Technology Transfer and Commercialization,  will promote the development of ... of being useful therapeutic targets for treating type 2 diabetes, hypertension and more recently a genetic disease associated with K ... translating academic research into meaningful outcomes for human health.” ...

    sommers - 02/25/2021 - 9:56am

  6. Vanderbilt University anti-inflammatory therapy licensed to Amytrx is now in clinical trials for eczema treatment

    ... The licensing agreement, facilitated by the  Center for Technology Transfer and Commercialization  and the Office of the Vice Provost ... by conducting preclinical studies in experimental models of human disease with high unmet need.   “The progression of this work ...

    sommers - 10/30/2020 - 12:45pm

  7. Tech Connect, Vol. 7, Issue 22: Forum highlights innovative approaches to bolstering biomedical research

    ... Bentley, M.S., assistant vice chancellor for the Center for Technology Transfer and Commercialization, described how his center, which ... Drug Development company to further discussions regarding human behavioral analysis technologies developed by Nilanjan Sarkar in the ...

    steelmk - 07/21/2017 - 3:39pm

  8. Tech Connect, Vol. 6, Issue 24: CTTC hosts medical device reimbursement talk

    ... Naqvi will be leaving CTTC and joining  Johns Hopkins Technology Ventures .  In his new role at JHTV, Hassan will lead a team ... a conference sponsored by  VUMC  and the Office for Human Research Protections, titled “The Changing Landscape of Research: Where ...

    steelmk - 11/10/2016 - 7:45am

  9. Tech Connect, Vol. 6, Issue 9: ReconFTI available on VU e-Innovations

    ... images can be used to delineate functional pathways in the human brain. These functional pathways may help neuroscientists understand how ... of the next generation backscatter interferometry technology invented by Darryl Bornhop and colleagues in the Department of ...

    steelmk - 11/15/2016 - 4:08pm

  10. The yin and yang of cell signaling

    ... Lawrence Marnett , PhD, and colleagues used CRISPR-Cas9 technology to generate stable knock-outs of LYPLA1 and/or LYPLA2 in mouse ... pathway, which has been implicated in development of human neurodegenerative diseases and cancer. This research was ...

    sommers - 02/21/2019 - 9:51am